•  
  •  
  •  
  •  

2025-12-23 14:24:54

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  INE805A01014

Stock Report

  • AION-Tech Solutions and Bulgarian Company Theoremus AD Sign MoU to Advance Multimodal Urban Mobility in India
  • Aion-Tech Solutions Ltd enters into MoU with Theoremus AD
  • AION-Tech Solutions Welcomes Chanakya Bellam to Board of Directors
  • AION-Tech's ROQIT partners with Indian Railways to transform sustainable, door-to-door parcel delivery in India
  • Goldstone Technologies Ltd changes name as AION-TECH Solutions Ltd
  • GTL+Quantron JV set to disrupt Mobility Solutions Industry for Fleet Management using AI
  • Goldstone Technologies Ltd and e-mobility major Quantron AG, forge JV to build digital platforms offering sustainability services
  • Goldstone Technologies Ltd completes acquisition of Equitas Technologies Pvt Ltd
  • Goldstone Technologies Ltd to acquire majority stake in Equitas Technologies Pvt Ltd
  • Goldstone Technologies Ltd allots 1,58,00,000 Equity Shares on Preferential Basis

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024